Brief: Invo Bioscience On June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request For Continued Listing On Nasdaq
INVO Bioscience Inc INVO.O :
* INVO BIOSCIENCE: ON JUNE 18, 2024, CO RECEIVED NOTICE
FROM
NASDAQ INFORMING CO WAS GRANTED REQUEST FOR CONTINUED LISTING ON
NASDAQ
Source text for Eikon: ID:n0001493152-24-024525
Further company coverage: INVO.O
Recent news on INVO Fertility
See all newsINVO Fertility Q2 revenue rises, partly on acquisitions
Invo Fertility Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Invo Fertility Inc Expected To Post A Loss Of 70 Cents A Share: Earnings Preview
Brief: INVO Fertility - Entered Into Any Market Purchase Agreement With Alumni Capital Lp
Invo Fertility Inc Reports Results For The Quarter Ended March 31: Earnings Summary